Abstract
Treatment of older patients with glioblastoma must take into account reduced treatment benefits and increased treatment-related toxicity, as this group of frail patients has a particularly poor prognosis. A new systematic review provides guidance for treating elderly patients, but decision-making in clinical practice faces many challenges.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 374-+ |
Journal | Nature Reviews Neurology |
Volume | 11 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2015 |
Research programs
- EMC MM-03-44-06